- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Therapy for Cancer
Authors
Keywords
-
Journal
Annual Review of Immunology
Volume 27, Issue 1, Pages 83-117
Publisher
Annual Reviews
Online
2008-11-14
DOI
10.1146/annurev.immunol.021908.132544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Appropriate Use of Cervical Cancer Vaccine
- (2008) Gregory D. Zimet et al. Annual Review of Medicine
- Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
- (2008) M. de la Luz Garcia-Hernandez et al. CANCER RESEARCH
- Capitalizing on the Immunogenicity of Dying Tumor Cells
- (2008) C. Fonseca et al. CLINICAL CANCER RESEARCH
- Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
- (2008) R. Berger et al. CLINICAL CANCER RESEARCH
- Cancer vaccines for established cancer: how to make them better?
- (2008) Daniel M. Andrews et al. IMMUNOLOGICAL REVIEWS
- Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines
- (2008) Masahisa Jinushi et al. IMMUNOLOGICAL REVIEWS
- The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
- (2008) David H. Lynch IMMUNOLOGICAL REVIEWS
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- RAGE signaling sustains inflammation and promotes tumor development
- (2008) Christoffer Gebhardt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
- (2008) Silvia Piconese et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma
- (2008) Maja A. Hofmann et al. JOURNAL OF IMMUNOTHERAPY
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
- (2008) Naomi N. Hunder et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod
- (2008) Manon van Seters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
- (2008) D. Atanackovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
- (2008) J. B. Swann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
- (2008) F. S. Hodi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer in inflammatory bowel disease
- (2008) Jianlin Xie et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started